Narrow search
Showing 1 - 10 of 319
Cover Image
Assessing Quality Improvement Infrastructure in the Formation of Accountable Care Organizations: A Regional Policy Analysis for the Pharmaceutical Industry
Carr-Whealy, Nathan - 2011
Accountable Care Organizations are developing in the United States as a result of the Patient Protection and Affordable Care Act. A study is needed to evaluate an emerging issue of ACOs, quality improvement infrastructure, and the pharmaceutical industry. The convergence of these topics has not...
Persistent link: https://www.econbiz.de/10009434765
Cover Image
Patientenaufklärung und Stellenwert hausärztlicher Pharmakotherapien in kommunalen Krankenhäusern
Sorns, Uwe - 2001
Persistent link: https://www.econbiz.de/10010353182
Cover Image
The Shingo Prize for Operational Excellence: Rewarding World-Class Practices
Chakravorty, Satya S.; Atwater, J. Bryan; Herbert, James I. - 2008
Established in 1988, the Shingo Prize for Operational Excellence recognises organisations in the USA, Mexico and Canada …
Persistent link: https://www.econbiz.de/10009459022
Cover Image
Determinants of the Relations between Transitory Earnings and CEO Cash Compensation in the USA
Asthana, Sharad; Ye, Zhongxia Shelly - 2007
effect). This study has practical implications for regulators, corporations and investors, both in the USA and abroad. …
Persistent link: https://www.econbiz.de/10009459069
Cover Image
A study of outsourcing of premedia services to India by US companies
Nayak, Rahul P. - 2009
Offshore outsourcing continues to gain prominence as the printing industrystrides into the future. With different segments of the industry looking at reducingcosts and, in exchange providing value-added services, more companies turntowards outsourcing services offshore as a solution. Although it...
Persistent link: https://www.econbiz.de/10009459219
Cover Image
Essays zur Kommerzialisierung innovativer Technologien durch Unternehmensgründungen
Arne Schmidt - 2010
Bereits Schumpeter (1934, 1942) beschreibt, wie technologischer Fortschritt die neuartige und wertschaffende Kombination von Ressourcen ermöglicht. Das dadurch entstehende Ungleichgewicht im Markt ermöglicht es Unternehmern, diese „Chancen“ zu verfolgen und neue Technologien in...
Persistent link: https://www.econbiz.de/10009429019
Cover Image
OS NOVOS RUMOS DA ESTRATÉGIA DE MARKETING NO MERCADO FARMACÊUTICO
Correa, Gisleine Fregoneze; Oliveira, Luciel Henrique de - 2008
The pharmaceutical industry invests its sales force in contacts with doctors, making visits and publicizing its drugs, in orderfor them to prescribe these products to their patients. This work discusses the structure of the pharmaceutical market and howmarketing strategies are used by...
Persistent link: https://www.econbiz.de/10009446936
Cover Image
Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act
Grabowski, Henry; Vernon, John - 1992
the 1962 Kefauver-Harris Amendments to theFood and Drug Act. This 1984 law, known as the Drug Price Competitionand Patent … Term Restoration Act (hereinafter the 1984 Act), facilitatedthe entry of generic drug products after patent expiration … while it alsorestored part of the patent life lost during the premarket regulatory processfor new introductions.1Market …
Persistent link: https://www.econbiz.de/10009475542
Cover Image
Substitution laws and innovation in the pharmaceutical industry.
Grabowski, Henry; Vernon, John - 1979
The pharmaceutical industry has been among the most innovative while being one of the most highly regulated industries in the United States. Government regulation of pharmaceutical product quality started in 19061 and has evolved into a stringent system of premarket controls over new drug...
Persistent link: https://www.econbiz.de/10009475544
Cover Image
Precedence of institutions over research environment in determining growth in Uttar Pradesh in India
Panda, Hrushikesh - 2008
Uttar Pradesh, in terms of per capita income the second poorest state in India in the year2004-05. The state however has a conducive research environment for development ofdrugs and pharmaceuticals industry with many central government organizations carryingout research related to the industry....
Persistent link: https://www.econbiz.de/10009475795